Hepatitis C virus genotypes in elderly patients with chronic hepatitis C

R Carrá1, G Elia, N Santangelo

  • 1Institute of Internal Medicine and Geriatrics, University of Catania, Ospedale Cannizzaro, Via Messina, 829, l-95126 Catania, Italy.

Insights

Hepatitis C virus (HCV) subtype 1b is prevalent in elderly patients in Eastern Sicily. This finding suggests subtype 1b is indigenous but not the sole prognostic factor for chronic hepatitis C (CHC) severity or interferon response in this age group.

Area of Science:

  • Hepatology
  • Virology
  • Epidemiology

Background:

  • Hepatitis C virus (HCV) genotype and subtype determination is crucial for understanding epidemiological characteristics.
  • HCV subtypes serve as prognostic factors for disease severity and interferon (IFN) treatment response in chronic hepatitis C (CHC).
  • Limited data exists on HCV genotype prevalence and its clinical implications in elderly CHC patients.

Purpose of the Study:

  • To determine HCV genotypes and subtypes in elderly CHC patients (65-75 years) in Eastern Sicily.
  • To gather epidemiological data on HCV genotype prevalence in this specific demographic.
  • To evaluate the relationship between HCV subtypes, disease severity, and IFN response in elderly patients.

Main Methods:

  • Study involved 22 elderly CHC patients (Group A, 65-75 years).
  • HCV-RNA subtypes were analyzed and compared with younger cohorts (Group B: 36-64 years; Group C: 20-35 years).
  • Prevalence of HCV subtypes was assessed across the age groups.

Main Results:

  • HCV-RNA was detected in 20 out of 22 elderly patients (90.9%).
  • HCV subtype 1b was the predominant subtype (100%) in the elderly group.
  • Other HCV subtypes were more frequent in younger patient groups, particularly in the youngest cohort.

Conclusions:

  • HCV subtype 1b appears to be indigenous to Eastern Sicily.
  • HCV subtype 1b alone cannot be considered the sole prognostic factor for disease severity or IFN response in elderly CHC patients.
  • Further research is needed to understand the complex interplay of HCV genotypes, age, and treatment outcomes.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
Genital Herpes01:23

Genital Herpes

Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...